Patients suing insulin makers over rising prices

The three largest manufacturers of insulin are accused of conspiring in a price-fixing scheme, driving up the cost of lifesaving drugs for millions of patients, according to a lawsuit filed Monday.

IN-DEPTH REPORT: Our ongoing investigation into rising prescription drug prices

The federal suit filed in Massachusetts accuses drug makers Sanofi, Novo Nordisk and Eli Lilly of raising the list prices of their products “in perfect lock step” for years.

The accusations center on the shadowy rebate system between drug makers and pharmacy benefit managers, which this news outlet has been investigating.

Read more about the lawsuit: Insulin makers accused of price-fixing scheme

More from our investigation:

About the Author